Physiologically Based Pharmacokinetic (PBPK) and Pharmacokinetic Pharmacodynamic (PKPD) modeling are two crucial branches of clinical pharmacology that study the effects of drugs on the body over time. PBPK modeling involves the application of mathematical models to simulate drug absorption, distribution, metabolism, and excretion, as well as the interaction between drug properties and the body. It is used to assess drug safety, dosing parameters, and side effects. Pharmacokinetics and pharmacodynamics (PK-PD) modeling is a statistical model that studies the interrelationship of both pharmacokinetics and pharmacodynamics of drugs to assess their dosage regime. PK-PD modeling offers a quantitative depiction of the drug’s absorption and elimination processes within the body, while PD modeling evaluates the effects of drugs on the body, considering the drug’s mechanism of action and primary biological mechanisms that restrict its rate of action. The relationship between drug exposure and response can be measured using PK and PD models. These models can also be employed to assess the impact of drug-specific, delivery system-specific, physiological, and pathological system-specific factors on this relationship. It is currently common practice for pharmaceutical companies to integrate the PBPK modeling strategy into the dossiers that they submit to regulatory bodies. In conclusion, PBPK and PKPD modeling are essential tools in drug development, risk assessment, and personalized medicine. They help predict drug absorption, distribution, metabolism, and excretion, as well as the effects of various factors on drug interactions. Future directions for PBPK and PKPD modeling include advances in modeling techniques and the integration of these models for comprehensive drug effect predictions.